2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$10.26+$0.29 (+2.86%)
Price as of Jun 23, 2026 7:01 PM EDT- $2.2BMarket Cap
- 19.12%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$10.26+$0.29 (+2.86%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 14.91% | 32.7M | +868,159 (+2.66%) | Mar 31, 2026 |
DEEP TRACK CAPITAL, LP | 8.99% | 19.7M | +11.6M (+59.00%) | Mar 31, 2026 |
BLACKROCK, INC. | 7.37% | 16.1M | +530,537 (+3.29%) | Mar 31, 2026 |
AVORO CAPITAL ADVISORS LLC | 5.62% | 12.3M | +1.5M (+12.48%) | Mar 31, 2026 |
SUMMER ROAD LLC | 5.43% | 11.9M | +771,270 (+6.49%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 5.41% | 11.8M | +492,323 (+4.16%) | Dec 31, 2024 |
VANGUARD GROUP INC | 5.29% | 11.6M | +2.4M (+20.84%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIDELITY MT VERNON STREET TRUST | 6.66% | 14.6M | -88,449 (-0.61%) | Feb 28, 2026 |
VANGUARD INDEX FUNDS | 3.88% | 8.5M | +187,824 (+2.21%) | Mar 31, 2026 |
iSHARES TRUST | 3.15% | 6.9M | -86,643 (-1.26%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 1.19% | 2.6M | +95,538 (+3.66%) | Feb 28, 2026 |
FIDELITY CONCORD STREET TRUST | 0.72% | 1.6M | +12,410 (+0.78%) | Feb 28, 2026 |
T. Rowe Price New Horizons Fund, Inc. | 0.67% | 1.5M | +1.5M (+100.00%) | Mar 31, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 0.66% | 1.4M | +1.4M (+100.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions1.8B (85.09%)
- Mutual Funds300.9M (13.87%)
- Insiders22.6M (1.04%)
- Other0 (0.00%)
Insider Transactions
- 1.04% (22.6M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $1.4MAmount of InsiderBuying (last 12 months)
- 6Number of InsiderSelling (last 12 months)
- $137.6MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Williams Leslie J. | Award | Jun 10, 2026 | $0.00 | 44,000 | $0.00 | 44,000 |
Hong Seung Suh | Award | Jun 10, 2026 | $0.00 | 44,000 | $0.00 | 44,000 |
Graves Adrienne L | Award | Jun 10, 2026 | $0.00 | 44,000 | $0.00 | 44,000 |
Hong Seung Suh | Award | Jun 10, 2026 | $0.00 | 14,000 | $0.00 | 60,933 |
Williams Leslie J. | Award | Jun 10, 2026 | $0.00 | 14,000 | $0.00 | 65,433 |
Graves Adrienne L | Award | Jun 10, 2026 | $0.00 | 14,000 | $0.00 | 64,000 |
Nayak Sanjay Chief Strategy Officer | Sell | Feb 23, 2026 | $14,564.52 | 1,759 | $8.28 | 330,653 |
Kaiser Peter Chief Development Officer | Sell | Feb 23, 2026 | $23,266.80 | 2,810 | $8.28 | 269,108 |
Dugel Pravin See Remarks | Sell | Feb 23, 2026 | $166,063.68 | 20,056 | $8.28 | 3.0M |
LINDSTROM RICHARD L MD | Buy | Feb 20, 2026 | $461,354.14 | 60,229 | $7.66 | 246,933 |
Waheed Nadia Chief Medical Officer | Sell | Feb 20, 2026 | $27,167.40 | 3,510 | $7.74 | 314,907 |
Notman Donald Chief Operating Officer | Sell | Feb 12, 2026 | $103,471.84 | 11,446 | $9.04 | 366,356 |
Waheed Nadia Chief Medical Officer | Sell | Feb 12, 2026 | $71,081.52 | 7,863 | $9.04 | 318,417 |
Dugel Pravin See Remarks | Sell | Feb 12, 2026 | $1.1M | 124,882 | $9.04 | 3.0M |
Nayak Sanjay Chief Strategy Officer | Sell | Feb 12, 2026 | $93,545.92 | 10,348 | $9.04 | 332,412 |
Notman Donald Chief Operating Officer | Sell | Feb 04, 2026 | $51,538.90 | 6,035 | $8.54 | 377,802 |
Notman Donald Chief Operating Officer | Sell | Feb 02, 2026 | $49,858.70 | 5,455 | $9.14 | 383,837 |
Robinson David Wayne Global CCO | Award | Jan 21, 2026 | $0.00 | 416,000 | $0.00 | 416,000 |
Robinson David Wayne Global CCO | Award | Jan 21, 2026 | $0.00 | 136,000 | $0.00 | 136,000 |
Robins Jason Shand Interim CFO | Award | Jan 20, 2026 | $0.00 | 33,000 | $0.00 | 33,000 |
Kaiser Peter Chief Development Officer | Award | Jan 02, 2026 | $0.00 | 240,932 | $0.00 | 240,932 |
Nayak Sanjay Chief Strategy Officer | Award | Jan 02, 2026 | $0.00 | 197,650 | $0.00 | 197,650 |
Saroj Namrata Chief Business Officer | Award | Jan 02, 2026 | $0.00 | 240,932 | $0.00 | 240,932 |
Meyers Steve Lawrence Chief Commercial Officer | Award | Jan 02, 2026 | $0.00 | 197,650 | $0.00 | 197,650 |
Kaiser Peter Chief Development Officer | Award | Jan 02, 2026 | $0.00 | 79,112 | $0.00 | 271,918 |
Nayak Sanjay Chief Strategy Officer | Award | Jan 02, 2026 | $0.00 | 64,900 | $0.00 | 342,760 |
Waheed Nadia Chief Medical Officer | Award | Jan 02, 2026 | $0.00 | 240,932 | $0.00 | 240,932 |
Anderman Todd Chief Legal Officer | Award | Jan 02, 2026 | $0.00 | 197,650 | $0.00 | 197,650 |
Heier Jeffrey S. Chief Scientific Officer | Award | Jan 02, 2026 | $0.00 | 240,932 | $0.00 | 240,932 |
Meyers Steve Lawrence Chief Commercial Officer | Award | Jan 02, 2026 | $0.00 | 64,900 | $0.00 | 217,628 |